Core Viewpoint - The Shenzhen National Biopharmaceutical Base (Pingshan) has been recognized as one of the top four biomanufacturing innovation bases in China, reflecting its significant progress in the biopharmaceutical industry over the past two decades [1][4]. Group 1: Industry Recognition and Growth - The Pingshan biopharmaceutical industry has been acknowledged for its innovation and development, evidenced by its inclusion in the "2025 Most Innovative Biomanufacturing Base" list [1][4]. - An international delegation from the U.S. praised Pingshan's complete industrial ecosystem during their visit, highlighting the area's advancements in biopharmaceutical technologies [3][4]. - Pingshan has established itself as a leading hub for biopharmaceuticals in Shenzhen, with a growing consensus among industry players that it is the preferred location for biopharmaceutical enterprises [4][6]. Group 2: Industry Infrastructure and Ecosystem - Pingshan has concentrated its efforts on strategic emerging industries, particularly biopharmaceuticals and high-end medical devices, with 1,290 biopharmaceutical companies currently operating in the area [6][7]. - The biopharmaceutical sector in Pingshan is projected to generate an output value of 26.78 billion yuan in 2024, maintaining its leading position in Shenzhen [6]. - The region has developed a robust industrial ecosystem, featuring major companies like Fosun Pharma and Sanofi Pasteur, alongside numerous innovative small and medium enterprises [6][7]. Group 3: Supportive Policies and Services - Pingshan has implemented a comprehensive service system for the biopharmaceutical industry, providing over 2.5 million square meters of high-standard industrial space for companies [9][10]. - The district has introduced financial support policies, including a biopharmaceutical and innovative drug special policy, and established a fund cluster exceeding 5 billion yuan to support innovation [10][12]. - A three-tiered service mechanism has been created to enhance efficiency in administrative processes, significantly reducing response times for companies [10][12]. Group 4: Future Development and Vision - Pingshan aims to continue its role as a leading biopharmaceutical innovation hub by leveraging its national base status and focusing on research, innovation, and industrial clustering [11][12]. - The area is expected to attract more global industry leaders and innovative projects, further solidifying its position in the global biopharmaceutical landscape [11][12].

Core Viewpoint - The article emphasizes the importance of industrial biotechnology in supporting China's sustainable development and innovation in the bio-economy, focusing on key technologies and research areas that can replace fossil resources with renewable carbon resources and enhance industrial processes through modern biotechnology [5][20]. Group 1: Research Focus - The research institute focuses on three strategic themes: replacing fossil resources with renewable carbon resources, using clean biological processing instead of traditional chemical methods, and enhancing industrial levels through modern biotechnology [5]. - Key research areas include industrial protein science and biocatalysis engineering, synthetic biology and microbial manufacturing engineering, and biological systems and bioprocess engineering [5]. Group 2: Team Introduction - Zhang Yiheng, a prominent researcher and doctoral supervisor, leads the Low Carbon Synthesis Engineering Biology National Key Laboratory and has made significant contributions to the field, including the establishment of the in vitro BioTransformation (ivBT) engineering technology system [6]. - Zhang Yuzhen, another researcher, has developed microfluidic technologies for quantitative studies of microbial populations and is working on high-throughput identification techniques for important industrial enzymes [7][8]. Group 3: Recruitment Information - The institute is seeking to hire 2-3 postdoctoral research assistants and 1-2 assistant researchers, with a focus on candidates holding doctoral degrees in microbiology, molecular biology, or enzyme engineering [9][10]. - Competitive salaries and benefits are offered, including social insurance, housing funds, and opportunities for professional development and overseas visits [11][12]. Group 4: Career Development - Postdoctoral researchers can apply for permanent positions with competitive salaries and development opportunities, including potential advancement to senior technical roles based on their research achievements [13][14]. Group 5: Upcoming Events - The article mentions an upcoming forum on non-grain biomass high-value utilization, scheduled for January 27-29, 2025, in Hangzhou, focusing on clean pretreatment of biomass and commercialization of bio-based materials and fuels [20].